AbCellera Biologics Inc vs Amylx Pharmaceuticals Inc — how do they compare? AbCellera Biologics Inc trades at $9.13 (market cap $2.99B), while Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B). The key difference: AbCellera Biologics Inc and Amylx Pharmaceuticals Inc are close in size by market cap. Which is the better fit depends on your goals.
| ABCL | AMLX | |
|---|---|---|
Market Cap | $2.99B | $2.64B |
Sector | Health | Health |
52-Week High | $9.76 | $24.19 |
52-Week Low | $2.78 | $7.82 |
Enterprise Value | $2.58B | $2.39B |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →